A survey was carried out of a population of workers exposed to tetrachlorophthalic anhydride, an acid anhydride epoxy resin curing agent known to cause asthma. Using a radioallergosorbent test with a tetrachlorophthalic anhydride human serum albumin conjugate, specific IgE antibody was detected in serum from 24 out of 300 factory floor workers exposed to tetrachlorophthalic anhydride. Of these 24, 20 (83-3%) were current smokers compared with 133 (48 2%) of 276 without antibody (p <0 01), and there was a weaker association with atopy, defined by skin tests with common allergens. Smoking and atopy interacted, the prevalence of antibody being 16 1% in atopic smokers, 11-7% in non-atopic smokers, 8-3% in atopic non-smokers, and nil in non-atopic non-smokers (p <0 025). Smoking may predispose to, and interact with atopy in, the production of specific IgE antibody to this hapten protein conjugate.
Introduction
Acid anhydrides are reactive chemicals of low molecular weight, which are used as curing agents in epoxy resins and have applications in reinforced plastics, casting, encapsulation, paints, and adhesives. Acting as haptens, acid anhydrides stimulate the formation of specific IgE antibody, which is implicated in the mechanism of the asthma caused by acid anhydrides. '-3 In the United Kingdom patients with occupational asthma caused by acid anhydrides are now entitled to industrial disease benefit.
In 1978 Schlueter et al reported that the acid anhydride tetrachlorophthalic anhydride caused asthma,4 and in 1983 we described a group of seven patients with asthma induced by tetrachlorophthalic anhydride and also showed specific IgE antibody in their serum in a radioallergosorbent test using a tetrachlorophthalic anhydride human serum albumin conjugate. 3 Only one of these seven patients was atopic, defined by skin re. ctivity to common environmental antigens, but all seven were smokers.
A survey of the population at the factory that had employed the patients in our first study3 provided an opportunity to study factors (particularly smoking) potentially predisposing people to asthma induced by tetrachlorophthalic anhydride. Paradoxically, patients are not ideal subjects for studies of risk factors in occupational asthma. They are often selected for medical referral because they have severe or complicated disease, and their symptoms may cause them to alter their working practices and other habits, like smoking, or may colour their recollection of events preceding the onset of asthma. The ability to detect specific IgE immunoglobulin against occupational agents causing asthma means that surveys can use a standard, objective case definition and also permits the study of healthy people with specific IgE who are without the symptoms that may lead a patient with asthma to modify his way of life.
Offices and other rooms Subjects and methods
THE FACTORY
The factory was used for the manufacture of electronic components, most of which were encapsulated in epoxy plastic containing tetrachlorophthalic anhydride. The encapsulation process was performed using uncured, premixed epoxy resin powder in coating machines whose positions are shown in figure 1 . The process allowed powder to escape into the environment, where it could be inhaled. The J7ob mapping-The subjects indicated their working positions on a large plan of the factory, on which a grid had been drawn. In this study current work area was used as an index of exposure to tetrachlorophthalic anhydride, and the subjects were divided into three exposure groups-coating area workers (areas 2 and 3 ( fig 1) ), other factory workers (area 1 Three subjects with specific IgE were excluded from this analysis because their atopic state was not known; two were current and one a former smoker. The two subjects with a skin reaction to tetrachlorophthalic anhydride human serum albumin conjugate but without serum antibody were non-atopic current smokers. In the interviews five workers gave histories consistent with work related asthma but in none could tetrachlorophthalic anhydride be implicated convincingly. Two had low concentrations of specific IgE (0 42°, and 0 47 ') but they, and a third subject, identified other agents as provoking their symptoms-a solder, an ink, and an unidentified black powder in use four years previously. All three had moved away from these materials and improved despite remaining exposed to tetrachlorophthalic anhydride. The two others with positive histories had also remained exposed to tetrachlorophthalic anhydride, and their asthma had not deteriorated. No The striking finding of the study was the association between smoking and specific IgE and the interaction between smoking and atopy. In workers exposed to the chemical the prevalence of antibody was over five times greater in smokers than in non-smokers, and, although the association with atopy was weaker, both smoking and atopy were related to specific IgE production. With both factors the antibody prevalence was 16 101), with smoking alone 1 1 70o, and with atopy alone 8 3 o; people without either factor, over one third of the exposed population, had not developed antibody. These results were not explained by differences in, for example, length of employment and suggest that smoking and, to a lesser extent, atopy predisposed to the development of specific IgE.
A similar association between smoking and specific IgE has been noted in a Swedish study of green coffee bean and ispaghula workers,6 although the effect of atopy on the association was not examined. This consistency suggests that the association may be causal. The mechanism is unknown, but as these protein antigens would be denatured by heat, exposure is unlikely to be enhanced in some way by smoking contaminated cigarettes. A possible explanation is that smoking increases antigen access to immunocompetent cells. Smokers' lungs are more permeable to inhaled agents,7 probably because of the acute inflammation produced by cigarette smoke.8 The longstanding "mucosal theory" of atopy proposes that increased mucosal permeability to antigenic material may explain atopy.9 It would also explain both the association with smoking and the interaction with atopy that we observed. Increased mucosal permeability also may be a factor in the higher mean concentration of total IgE observed in smokers in the general population.10
The 24 workers found to have specific IgE did not have asthma induced by tetrachlorophthalic anhydride and differed from our original patients in having a lower mean antibody concentration and a lower prevalence of skin reactivity to tetrachlorophthalic anhydride human serum albumin conjugate. These differences may reflect current exposure to tetrachlorophthalic anhydride, which was lower during the survey than when the patients were diagnosed; they may reflect clinical state, with asymptomatic antibody production and clinical asthma representing the ends of a spectrum of disease. The prognostic significance of asymptomatic antibody production is unknown without further investigation.
Extrapolating Despite the successful clinical use of support hose for many years the exact amount of compression required to give maximum benefit to patients with varicose veins is still disputed.1 2 Physiological studies have shown that the tension and pressure of support hose should be close to the capillary pressure,3-5 but as the capillary pressure varies with posture and the distance from the heart this is technically difficult to achieve. We investigated the acceptability of a stocking that is claimed by the manufacturer (Sigvaris, Ganzoni, St Gallen, Switzerland) to provide graduated support with a pressure of roughly 40 mm Hg at the level of the ankle.
Patients, methods, and results
Patients were selected sequentially from a surgical waiting list, starting with those added most recently. They were randomised into two groups and given stockings that provided either 30-40 mm Hg or 40-50 mm Hg pressure. For each patient a history was taken and an examination made for the presence of pain, eczema, and ulceration and the extent of varicosities. The patients were fitted with support hose below the knee and asked to wear the stockings for six weeks. They were then reviewed blind, particular attention being paid to tolerance of the stockings and whether symptoms were better, worse, or unchanged.
Altogether 163 patients were asked to take part in the trial. Twenty five did not reply because they had moved from the area, four had had operations elsewhere, and 30 declined to participate. 
Comment
We reduced our waiting list by 51 patients simply by conducting this trial. Of the 104 patients who took part in the trial, 8C claimed that the stockings were comfortable. In the remaining group of patients the main cause of discomfort was not simply that they were too tight. In answer to the proponents of low pressure stockings, most of our patients found the higher pressure stockings tolerable and roughly one quarter found them sufficiently acceptable that they decided not to undergo surgery. We could have increased the acceptability of the stockings by varying their weight and length (for example, above knee length or tights), but for consistency within the trial we did not offer different styles to the patients.
We accept that the study was biased towards surgery because patients were taken from the waiting list and therefore may have considered stockings to be second best; but we believe that this bias was probably offset by our giving those patients who were not keen on surgery an alternative method of treatment. Despite these reservations we believe that the trial showed that most patients with simple varicose veins tolerate pressures of about 40 mm Hg and that suggestions that lower pressures are more acceptable are too cautious.'
We thank Lesley Davies for typing the manuscript, Mr L James, who acted as fitter, and Sigvaris Company for providing the stockings. Many diabetics take combinations of short and intermediate acting insulin, and they often mix them in the syringe before administration. ' We have recently shown that mixing short acting and isophane insulins in the syringe does not affect the absorption kinetics of the short acting insulin, whereas its activity is delayed when it is combined with lente insulin.2 This study compared the effects of mixtures of short acting with lente and short acting with isophane insulins on postprandial blood glucose and plasma free insulin concentrations in type I diabetics.
Patients, methods, and results
We studied 13 tvpe I diabetics aged 19-64 who did not secrete endogenous insulin. They were treated with twice daily mixtures of short and inter-
